Bank of Montreal’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Bank of Montreal's BIIB Position: Q2 2026 in Review
Bank of Montreal increased its Biogen (BIIB) stake by 34% in Q2 2026, buying an estimated $6.04M and bringing the position to 124,267 shares worth $26.8M. The position accounts for 0.01% of the portfolio, ranked #800.
Bank of Montreal first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $123M in Q4 2018. 746 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Bank of Montreal held 124,267 shares of Biogen worth $26.8M as of Q2 2026.
- Bank of Montreal bought 31,558 Biogen shares in Q2 2026, an estimated $6.04M.
- Biogen made up 0.01% of Bank of Montreal's portfolio in Q2 2026, its #800 holding.
- Bank of Montreal first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Bank of Montreal's Biogen position peaked at $123M in Q4 2018.
- 746 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.